4/A

FORM 4/A SUBMISSION

Company: Larimar Therapeutics, Inc.
Filed: October 20, 2015
Period of Report: September 14, 2015
Accession Number: 0000899243-15-006923

View Document ↗ View on SEC.gov ↗